Though Sequencers Improve Performance, $10,000 Genome Remains Elusive in '08, Survey Finds

The survey, conducted by In Sequence, also showed that many users of second-gen sequencers made by Illumina, 454, and ABI struggled with technical problems.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.